Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls

Not yet recruiting

Phase N/A Results N/A

Trial Description

The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies.
The investigators believe that minor antibodies have a major role in the hypercoagulability state.

Conditions

Trial Design

  • Observation: Case Control
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Trial Population

on a bank of 207 stroke patients serum samples, and also on 40 healthy controls. The samples were collected during the acute phase of the ischemic event.

Outcomes

Type Measure Time Frame Safety Issue
No outcomes associated with this trial.

Biospecimen Retention:Samples Without DNA - Serum samples of Stroke patients withdrawned within 36 hrs since stroke evoked. Healthy controls

Sponsors